Dopamine signaling negatively regulates striatal phosphorylation of Cdk5 at tyrosine 15 in mice

Frontiers in Cellular Neuroscience

Volumn 7, Issue FEB, 2013, Pages

  Yamamura, Yamamura ^a,b   Morigaki, Ryoma ^a,b   Kasahara, Jiro ^b   Yokoyama, Hironori ^b   Tanabe, Akie ^b   Okita, Shinya ^a,b   Koizumi, Hidetaka ^c   Nagahiro, Shinji ^a,b   Kaji, Ryuji ^a,c   Goto, Satoshi ^a,b,c  

^a TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Cell signaling; Cyclin dependent kinase 5; Phosphorylation; Striatum

Indexed keywords

1 AMINOMETHYL 5, 6 DIHYDROXY 3 PHENYLISOCHROMAN; 1, 2, 3, 6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; APOMORPHINE; CYCLIN DEPENDENT KINASE 5; DOPAMINE; IMATINIB; LEVODOPA; UNCLASSIFIED DRUG;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRIFUGATION; CONTROLLED STUDY; DENSITOMETRY; DIGITAL IMAGING; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; OPTICAL DENSITY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; STRIATE CORTEX; WESTERN BLOTTING;

EID: 84877245923     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2013.00012     Document Type: Article

References (32)

1. Aoki, E., Yano, R., Yokoyama, H., Kato, H., and Araki, T. (2009). Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine)- induced apoptosis in nigral neurons of mice. Exp. Mol. Pathol. 86, 57-64.
2. Bibb, J. A., Chen, J., Taylor, J. R., Svenningsson, P., Nishi, A., Snyder, G. L., et al. (2001). Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 410, 376-380.
3. Bonito-Oliva, A., Feyder, M., and Fisone, G. (2011). Deciphering the actions of antiparkinsonian and antipsychotic drugs on cAMP/DARPP-32 signaling. Front. Neuroanat. 5:38. doi: 10.3389/fnana.2011.00038
4. Brown, A. M., Deutch, A. Y., and Colbran, R. J. (2005). Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism. Eur. J. Neurosci. 22, 247-256.
5. Calabresi, P., Di Filippo, M., Ghiglieri, V., Tambasco, N., and Picconi, B. (2010). Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap. Lancet Neurol. 9, 1106-1117.
6. Capdeville, R., Buchdunger, E., Zimmermann, J., and Matter, A. (2002). Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug. Nat. Rev. Drug Discov. 1, 493-502.
7. Chartoff, E. H., Marck, B. T., Matsumoto, A. M., Dorsa, D. M., and Palmiter, R. D. (2001). Induction of stereotypy in dopamine-deficient mice requires striatal D1 receptor activation. Proc. Natl. Acad. Sci. U.S.A. 98, 10451-10456.
8. Chergui, K., Svenningsson, P., and Greengard, P. (2004). Cyclin- dependent kinase 5 regulates dopaminergic and glutamater- gic transmission in the striatum. Proc. Natl. Acad. Sci. U.S.A. 101, 2191-2196.
9. Dhariwala, F. A., and Rajadhyaksha, M. S. (2008). An unusual member of the CDK family: CDK5. Cell. Mol. Neurobiol. 28, 351-369.
10. Dhavan, R., and Tsai, L. H. (2001). A decade of Cdk5. Nat. Rev. Mol. Cell Biol. 2, 749-759.
11. Fernandez, E., Schiappa, R., Girault, J.-A., and Novere, N. L. (2006). DARPP-32 is a robust integrator of dopamine and glutamate signals. PLoS Comput. Biol. 2:e176. doi: 10.1371/journal.pcbi.0020176
12. Feyder, M., Bonito-Oliva, A., and Fisone, G. (2011). L-DOPA- induced dyskinesias and abnormal signaling in striatal medium spiny neurons: focus on dopamine D1 receptor-mediated transmission. Front. Behav. Neurosci. 5:71. doi: 10.3389/fnbeh.2011.00071
13. Greengard, P. (2001). The neurobiology of slow synaptic transmission. Science 294, 1024-1030.
14. Hisanaga, S.-I., and Endo, R. (2010). Regulation and role of cyclin- dependent kinase activity in neuronal survival and death. J. Neurochem. 115, 1309-1321.
15. Hof, P. R., Young, W. G., Bloom, F.E., Belichenko, P. V., and Celio, M. R. (2000). Comparative Cytoarchitectonic Atlas of the c57bl/6 and 129/sv Mouse Brain. Amsterdam: Elsevier.
16. Kasahara, J., Fukunaga, K., and Miyamoto, E. (2001). Activation of calcium/calmodulin-dependent protein kinase IV in long term potentiation in rat hippocampal CA1 region. J. Biol. Chem. 276, 24044-24050.
17. Morigaki, R., Sako, W., Okita, S., Kasahara, J., Yokoyama, H., Nagahiro, S., et al. (2011). Cyclin-dependent kinase 5 with phosphorylation of tyrosine 15 residue is enriched in striatal matrix compartment in adult mice. Neuroscience 189, 25-31.
18. Murer, M. G., and Moratalla, R. (2011). Striatal signaling in L-DOPA- induced dyskinesias: common mechanisms with drug abuse and long term memory involving D1 dopamine receptor stimulation. Front. Neuroanat. 5:51. doi: 10.3389/fnana.2011.00051
19. Okita, S., Morigaki, R., Koizumi, H, Nagahiro, S., Kaji, R., and Goto, S. (2012). Cell type-specific localization of optineurin in the striatal neurons of mice: implications for neuronal vulnerability in Huntington's disease. Neuroscience 202, 363-370.
20. Ouimet, C. C., Langley-Gullion, K. C., and Greengard, P. (1998). Quantitative immunocytochem- istry of DARPP-32-expressing neurons in the rat caudatoputamen. Brain Res. 808, 8-12.
21. Sako, W., Morigaki, R., Nagahiro, S., Kaji, R., and Goto, S. (2010). Olfactory type G-protein a subunit (Gaolf) in striosome- matrix dopamine systems in adult mice. Neuroscience 170, 497-502.
22. Santini, E., Valjent, E., Usiello, A., Carta, M., Borgkvist, A., Girault, J. A., et al. (2007). Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in l-dopa- induced dyskinesia. J. Neurosci. 27, 6995-7005.
23. Sato, K., Sumi-Ichinose, C., Kaji, R., Ikemoto, K., Nomura, T., Nagatsu, L, et al. (2008). Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dystonia. Proc. Natl. Acad. Sci. U.S.A. 105, 12551-12556.
24. Schlatterer, S. D., Acker, C. M., and Davies, P. (2011). c-Abl in neurode- generative disease. J. Mol. Neurosci. 45, 445-452.
25. Smith, D. S., and Tsai, L.-H. (2002). Cdk5 behind the wheel: a role in trafficking and transport? Trends Cell Biol. 12,28-36.
26. Surmeier, D. J., Ding, J., Day, M., Wang, Z., and Shen, W. (2007). D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci. 30,228-235.
27. Svenningsson, P., Nishi, A., Fisone, G., Girault, J. A., Nairn, A. C., Greengard, P. (2004). DARPP-32: an integrator of neurotransmission. Annu. Rev. Pharmacol. Toxicol. 44, 269-296.
28. Takahashi, S., Ohshima, T., Cho, A., Sreenath, T., Iadarola, M. J., Pant, H. C., et al. (2005). Increased activity of cyclin-dependent kinase 5 leads to attenuation of cocaine- mediated dopamine signaling. Proc. Natl. Acad. Sci. U.S.A. 102, 1737-1742.
29. Yger, M., and Girault, J.-A. (2011). DARPP-32, jack of all trades.master of which? Front. Behav. Neurosci. 5:56. doi: 10.3389/fnbeh.2011.00056
30. Yokoyama, H., Yano, R., Kuroiwa, H., Tsukada, T., Uchida, H., Kato, H., et al. (2010). Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1, 2, 3, 6- tetrahydropyridine) neurotoxicity in mice. Metab. Brain Res. 25, 135-143.
31. Zhang, B., Tan, V. B. C., Lim, K. M., and Tay, T. E. (2007). The activation and inhibition of cyclin-dependent kinase-5 by phosphorylation. Biochemistry 46, 10841-10851.
32. Zukerberg, L. R., Patrick, G. N., Nikolic, M., Humbert, S., Wu, C. L., Lanier, L. M., et al. (2000). Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth. Neuron 26, 633-646.